| Up-to-date management of gout. | |
| | |
MedLine Citation:
|
PMID: 22301867 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: Gout is a true crystal deposition disease, extremely painful and bone and tissue damaging if untreated. It is the only curable form of arthritis. Although we have many treatments to cure gout, it is a disease that is consistently undertreated/mismanaged and perceived by clinicians and the lay public as a 'laughable condition' with the patients' lifestyle often held erroneously to account. This article would give you a good understanding of modern and established pharmacological and nonpharmacological treatments used in the management of acute and chronic gout and how to 'treat to target' to cure the disease. RECENT FINDINGS: Many of the drugs we use to manage patients with gouty arthritis have been in existence since the 1970s and 1980s. In the past few years, because of the improved physiological understanding of gout, new innovative treatments such as anti-IL inhibitors, a nonxanthine oxidase inhibitor and the uricase enzymes have been developed adding to our armamentarium of drugs. SUMMARY: With the introduction of new research, we have been able to explore how to also use established treatments more effectively, raising the profile of gout and its best management and introducing the principle of treating the patient to urate target. |
| | |
Authors:
|
Kelsey M Jordan |
Related Documents
:
|
22272587 - Individual diversity management and salutogenic functioning. 16442447 - Succession planning. 10597157 - A review of the expanding field of exotic animal oral health care--veterinary dentistry. 22317647 - The ambivalence of the work of the hotel managers: an approach to ergonomics. 18084857 - Certification and credentialing to define competency-based practice. 19377717 - Use of active management of the third stage of labour in seven developing countries. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current opinion in rheumatology Volume: 24 ISSN: 1531-6963 ISO Abbreviation: Curr Opin Rheumatol Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-02-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9000851 Medline TA: Curr Opin Rheumatol Country: United States |
Other Details:
|
Languages: eng Pagination: 145-51 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Imaging in gout: insights into the pathological features of disease.
Next Document: Drug-induced rheumatic diseases: a review of published case reports from the last two years.